ROLE SUMMARY
Pfizer ORU (Oncology Research Unit) is seeking a Director to lead the Bioanalytical team responsible for Large and Small-molecule characterization in our ADC Discovery organization. The Bioanalytical team is an integral part of Protein and Bioanalytical Sciences (PBS) group within Pfizer ORU. This multidisciplinary team is at the forefront of characterizing the small molecules, antibodies, antibody-drug conjugates (ADCs) and novel protein technologies. The team responsibilities include stability testing of new therapeutic compositions, the bioanalytical assessment of ADC payload release, cellular deposition, exploration of new delivery technology formats, and assessment of binding affinity for both small and large molecules. The appointed leader will drive a dynamic and collaborative team, focusing on expanding technological capabilities to enhance the capacity and efficiency of key deliverables, crucial for advancing the discovery of novel ADCs aimed at cancer treatment. As a strategic and operational cornerstone, the team leader will collaborate with other senior members of the ADC Discovery Research Group to build and drive Pfizer's ADC strategy and advance Pfizer's preclinical pipeline.
KEY RESPONSIBILITIES
Lead a team of 6+ scientists including PhD level.Create and manage sub-team prioritization efforts within the group to ensure optimal portfolio progression and scientific rigor.Develop the strategies to improve capacity and efficiency of platform technologies through innovation and application of new technologies e.g. automation, platforms, workflows and externalization.Leverage new technologies and existing bioanalytical approaches to characterize protein biologics and ADC mechanisms of actionWork closely with early Research and Process Sciences departments to balance priorities and ensure efficient transfer of knowledge and processes from Discovery to the Pharmaceutical Sciences teamRepresent the team in governance forums and advocate for teams’ visibilityProvide supervision and mentorship, establishing the vision, implementation of new technologies and enabling personal growth of team membersPromote a culture of professionalism and collaboration focused on patient outcomes in alignment with company goals and valuesREQUIRED QUALIFICATIONS
Ph.D. in Biochemistry, Chemistry or related disciplineMinimum 7+ years with Ph.D. or 9+ years post MS related oncology or chemistry experience in industry, including technical and scientific experience in drug discovery and preclinical developmentExpertise in ADCs, including understanding of drug linker and small molecule biochemical conjugation, and in vitro and in vivo molecule stability characterizationExpertise in protein-protein and small molecule binding kinetics using BLI or SPR technologiesExpertise in analytical method development across for various biotherapeutic modalities.Deep understanding of antibody binding behavior with antigens and Fc receptors, including FcRn.Technical expertise in mass spectrometry in both large and small molecules across various vendor platformsCMC experience in project progression from research to development Deep experience in building, leading and directly managing teams, capable of giving feedback, coach, mentor, and develop employees Demonstrated track record in collaborative research in ADC Oncology drug discovery programs with strong business acumen and communication skillsAbility to collaborate across teams and a variety of disciplines to create and communicate scientific strategy and prioritiesPREFERRED QUALIFICATIONS
Strong track record of scientific accomplishments in industry as evidenced by publications or other equivalent achievementsExperience getting results through creativity and unique problem solvingRelocation support available
Work Location Assignment: Bothell, Washington
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.
Research and Development